TELA Bio, Inc. (TELA) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US8723811084
TELA Bio, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 80.28 m USD |
| Gross profit | 54.34 m USD |
| Operating income | -33.76 m USD |
| EBIT | -33.36 m USD |
| Net income | -38.83 m USD |
| Diluted EPS – continuing operations | -0.83 USD |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About TELA Bio, Inc.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
More stocks
- Koil Energy Solutions, Inc. (KLNG)
- Marwynn Holdings, Inc. (MWYN)
- Star Equity Holdings, Inc. (STRR)
- Sow Good Inc. (SOWG)
- Rein Therapeutics, Inc. (RNTX)
- NextBoat Inc. (NXB)
- INTERPACE BIOSCIENCES, INC. (IDXG)
- Emerita Resources Corp (EMO.V)
- Axil Brands, Inc. (AXIL)
- GameSquare Holdings, Inc. (GAME)
- InfraCom Group AB (INFRA.ST)
- Intellicheck, Inc. (IDN)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.